A previously unknown microprotein hidden within the human mitochondrial genome may help explain certain forms of type 2 diabetes and could point toward a new precision medicine approach to treating it, according to a new USC study.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗